Trial Profile
Effects of Interleukin-1 Receptor Antagonism on Hyperandrogenemia in Women With Polycystic Ovary Syndrome - a Prospective, Interventional, Single-arm, Open-label, Proof-of-concept Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Anakinra (Primary) ; Dexamethasone
- Indications Polycystic ovary syndrome
- Focus Proof of concept; Therapeutic Use
- Acronyms FertIL
- 26 Jan 2021 Status changed from recruiting to completed.
- 05 May 2020 Planned number of patients changed from 32 to 18.
- 24 Sep 2019 Planned End Date changed from 1 Oct 2019 to 1 Dec 2020.